First, we found that a systemic treatment of animals for five days with the LPA1 blocker did not alter tumor growth as judged by the absence of difference in the volume of PC3 tumors in animals treated with Ki16425 compared to vehicle-treated mice (Figure 4A). This evidence concerns the gene LPAR1 and neoplasm.